Skip to main content
. 2022 Aug;84(3):506–515. doi: 10.18999/nagjms.84.3.506

Table 2.

Surgical conditions [n (%)] (x ± s)

Group n Operative site [n (%)] Operation
time
(min)
Extubation
time
(min)
Length of
hospital
stay after
operation (d)
Dexmedetomidine
(μg)
Propofol
(mg)
Remifentanil
(μg)
Sufentanil
(μg)
Time of
first pressing
PCA pump
(h)
PCA pump
pressing
(n)
Pethidine
use
[n (%)]
Left lung Right lung
Control 44 21 (47.73) 23 (52.27) 128.79±24.63 135.76±46.94 6.27±1.83 43.28±15.06 307.54±34.86 11.25±3.62 132.14±16.13 10.14±1.27 5.86±1.73 7 (15.91)
TPVB 44 24 (54.55) 20 (45.45) 130.12±24.57 136.28±47.59 6.04±1.78 42.96±14.87 310.28±35.19 11.17±3.59 102.35±12.02a 13.09±1.82a 2.61±1.22a 3 (6.82)
SAPB 44 22 (50.00) 22 (50.00) 129.48±24.52 135.91±47.25 5.98±1.75 43.07±14.95 309.46±35.04 11.21±3.64 101.78±11.89a 12.58±1.76a 2.47±1.15a 2 (4.55)
χ2/F 0.424 0.356 0.152 0.639 0.139 0.527 0.258 9.674 7.819 10.269 3.850
P 0.809 0.710 0.859 0.542 0.623 0.795 0.617 <0.001 <0.001 <0.001 0.146

PCA: patient-controlled intravenous analgesia

SAPB: serratus anterior plane block

TPVB: thoracic paravertebral nerve block

aP<0.05 vs control group